TAP Sleep Care highlighted clinical evidence on Combination Therapy for CPAP-Resistant Obstructive Sleep Apnea from Martin A. Denbar, DDS, DABDSM, Diplomate of the American Board of Dental Sleep Medicine and Adjunct Assistant Professor in the Department of Internal Medicine at Texas A&M School of Medicine (Texas Dental Sleep Services). The […]
ARTICLES
U.S. FDA Approves Takeda’s ORZEYFUL (oveporexton), the First and Only Orexin Agonist for Narcolepsy Type 1
Takeda announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. […]
New Treatment Approach for Severe Sleep Disorders
Nightmares are among the most agonizing symptoms of post-traumatic stress disorder (PTSD) – a condition that can develop after exposure to severe traumatic experiences, such as disasters, serious accidents, acts of violence, or wartime experiences. Individuals affected relive the events intensely at night, as if they were real, time and […]
AI Identifies Previously Unrecognized Health Insights in Routine Sleep Studies
A novel AI model can use information collected during routine sleep studies to identify patients’ long-term health risks, according to a new study published in Nature Communications. Developed by a multidisciplinary research team, the model uncovered hidden sleep patterns linked to risks including heart disease, cognitive decline and death. The […]
FDA Approves Takeda’s Orzeyful, the First-Ever Orexin Agonist for Narcolepsy Type 1
The U.S. Food and Drug Administration today approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults. Orzeyful is the first medicine approved for narcolepsy type 1 as a complete disorder — addressing the full range of symptoms that define the condition — and the first to […]
New Study Uses Sleep Monitoring and AI to Detect Alzheimer’s
Researchers from Universidad Carlos III de Madrid (UC3M) and Hospital Universitario Severo Ochoa in Leganés, part of the public health network of the Comunidad de Madrid, have developed a methodology that uses artificial intelligence (AI) to analyze brain electrical activity during sleep and facilitate the early diagnosis of Alzheimer’s. The […]
Bridging the Communication Gap in Sleep Medicine
In sleep medicine, a profound communication barrier persists: the patient’s lived experience is often lost in translation. While clinicians use precise terms like polysomnogram, patients hear a “sleep study” — or worse, they dismiss lifelong, devastating exhaustion as simply “normal.” In a world where words like tired, fatigued, and sleepy […]
New Soft Wearable Device Could Support At-Home Sleep Monitoring
Good sleep is essential for brain health. During sleep and rest, the glymphatic system, the brain’s waste clearing process, helps remove metabolic waste that accumulates during awake hours. This activity is linked to memory processing, cognitive function, and neural recovery. When sleep quality is poor, metabolic waste may accumulate, potentially […]
Family, Work, and Mental Health Among Leading Factors Impacting Sleep in Adults
For many Americans, a good night’s sleep is easier said than done. According to a survey from the American Academy of Sleep Medicine, the pressures of daily life impact how well adults sleep. Topping the list, nearly half of adults (45%) say that family responsibilities have a major or moderate […]
Get Better Sleep With Ultrasound Patch That Boosts REM Rest
In a sleep management breakthrough, a University of Texas at Austin-led team of researchers has developed a noninvasive patch that boosts REM sleep in real-world trials without surgery or medication. The technology, called NEUSLeeP, is a soft, wearable device that uses gentle ultrasound waves and electrodes to stimulate deep brain […]













